APA

Gerards M. C., de Maar J. S., Steenbruggen T. G., Hoekstra J. B. L., Vriesendorp T. M. & Gerdes V. E. A. (20171031). Add-on treatment with intermediate-acting insulin versus sliding-scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy: a randomized crossover study. : Diabetes, obesity & metabolism.

Chicago

Gerards M C, de Maar J S, Steenbruggen T G, Hoekstra J B L, Vriesendorp T M and Gerdes V E A. 20171031. Add-on treatment with intermediate-acting insulin versus sliding-scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy: a randomized crossover study. : Diabetes, obesity & metabolism.

Harvard

Gerards M. C., de Maar J. S., Steenbruggen T. G., Hoekstra J. B. L., Vriesendorp T. M. and Gerdes V. E. A. (20171031). Add-on treatment with intermediate-acting insulin versus sliding-scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy: a randomized crossover study. : Diabetes, obesity & metabolism.

MLA

Gerards M C, de Maar J S, Steenbruggen T G, Hoekstra J B L, Vriesendorp T M and Gerdes V E A. Add-on treatment with intermediate-acting insulin versus sliding-scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy: a randomized crossover study. : Diabetes, obesity & metabolism. 20171031.